A pan-cancer survey of cell line tumor similarity by feature-weighted molecular profiles

被引:9
|
作者
Sinha, Rileen [1 ,6 ]
Luna, Augustin [2 ,4 ,5 ]
Schultz, Nikolaus [3 ]
Sander, Chris [2 ,4 ,5 ]
机构
[1] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA
[2] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02215 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Computat Oncol, New York, NY 10065 USA
[4] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA
[5] Broad Inst MIT & Harvard, Boston, MA 02142 USA
[6] Dana Farber Canc Inst, Dept Informat & Analyt, Boston, MA 02215 USA
来源
CELL REPORTS METHODS | 2021年 / 1卷 / 02期
关键词
cancer genomics; cancer therapy; CCLP; cell lines; decision support; oncogenic alterations; patient stratification; TCGA; web application; weighted similarity;
D O I
10.1016/j.crmeth.2021.100039
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Patient-derived cell lines are often used in pre-clinical cancer research, but some cell lines are too different from tumors to be good models. Comparison of genomic and expression profiles can guide the choice of preclinical models, but typically not all features are equally relevant. We present TumorComparer, a computational method for comparing cellular profiles with higher weights on functional features of interest. In this pan-cancer application, we compare similar to 600 cell lines and similar to 8,000 tumor samples of 24 cancer types, using weights to emphasize known oncogenic alterations. We characterize the similarity of cell lines and tumors within and across cancers by using multiple datum types and rank cell lines by their inferred quality as representative models. Beyond the assessment of cell lines, the weighted similarity approach is adaptable to patient stratification in clinical trials and personalized medicine.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Tumor characterization and stratification by integrated molecular profiles reveals essential pan-cancer features
    Zhaoqi Liu
    Shihua Zhang
    BMC Genomics, 16
  • [2] Tumor characterization and stratification by integrated molecular profiles reveals essential pan-cancer features
    Liu, Zhaoqi
    Zhang, Shihua
    BMC GENOMICS, 2015, 16
  • [3] PCTA, a pan-cancer cell line transcriptome atlas
    Cheng, Siyuan
    Li, Lin
    Yu, Xiuping
    CANCER LETTERS, 2024, 588
  • [4] Pan-cancer molecular analysis of the RB tumor suppressor pathway
    Erik S. Knudsen
    Ram Nambiar
    Spencer R. Rosario
    Dominic J. Smiraglia
    David W. Goodrich
    Agnieszka K. Witkiewicz
    Communications Biology, 3
  • [5] Pan-cancer molecular analysis of the RB tumor suppressor pathway
    Knudsen, Erik S.
    Nambiar, Ram
    Rosario, Spencer R.
    Smiraglia, Dominic J.
    Goodrich, David W.
    Witkiewicz, Agnieszka K.
    COMMUNICATIONS BIOLOGY, 2020, 3 (01)
  • [6] Pan-Cancer Survey of Tumor Mass Dormancy and Underlying Mutational Processes
    Wiecek, Anna Julia
    Jacobson, Daniel Hadar
    Lason, Wojciech
    Secrier, Maria
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [7] A pan-cancer fingerprint: common molecular denominators of the human tumor microenvironment
    Susanna S. Ng
    Sonia Leonardelli
    Michael Hölzel
    Signal Transduction and Targeted Therapy, 6
  • [8] Pan-cancer survey of lncRNA rewiring and functional alternation in tumor-infiltrating T cell by scLNC
    Lei, Yang
    Meng, Qianqian
    Hong, Fang
    Zhao, Mengyu
    Gao, Xin
    CANCER LETTERS, 2023, 569
  • [9] A pan-cancer fingerprint: common molecular denominators of the human tumor microenvironment
    Ng, Susanna S.
    Leonardelli, Sonia
    Hoelzel, Michael
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [10] Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome
    Bhattacharyya, Rupam
    Ha, Min Jin
    Liu, Qingzhi
    Akbani, Rehan
    Liang, Han
    Baladandayuthapani, Veerabhadran
    JCO CLINICAL CANCER INFORMATICS, 2020, 4 : 399 - 411